Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-07 Sale | 2024-05-09 4:10 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 236 | $7.76 | $1,831 | 11,571 (Direct) | View |
| 2024-03-08 Sale | 2024-03-08 6:05 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance | 4,884 | $11.72 | $57,219 | 11,807 (Direct) | View |
| 2024-03-04 Purchase | 2024-03-05 4:15 pm | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 43,360 | $11.35 | $492,028 | 43,360 (Direct) | View |
| 2023-05-10 Sale | 2023-05-11 4:12 pm | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer | 210 | $3.31 | $695 | 15,992 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-12 Option Award | 2024-11-14 4:15 pm | N/A 2034-11-11 | Fulcrum Therapeutics Inc. | FULC | King Rachel K. Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2024-09-23 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 18,729,099 (Indirect) | View |
| 2024-08-21 Other | 2024-08-23 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 8,500,000 | $0 | 20,109,704 (Indirect) | View |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $3.27 | 2,473,760 (Direct) | View |
| 2024-07-03 Exercise | 2024-07-08 08:00 am | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 150,000 | $0 | 2,473,760 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:20 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-16 | Fulcrum Therapeutics Inc. | FULC | Hill Colin Director | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2024-06-18 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Hill Colin Director | 0 | $0 | 0 (Direct) | View |
| 2024-03-18 Option Award | 2024-03-20 4:15 pm | N/A 2034-03-17 | Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2024-03-20 4:10 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 9:10 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance | 93,820 | $0 | 93,820 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 9:05 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-26 Option Award | 2024-01-30 9:00 pm | N/A 2034-01-25 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:15 pm | 2024-02-07 2033-08-06 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 61,822 | $0 | 61,822 (Direct) | View |
| 2023-08-07 Option Award | 2023-08-09 4:16 pm | N/A 2033-08-06 | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 432,800 | $0 | 432,800 (Direct) | View |
Ownership | 2023-08-09 4:11 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2023-07-03 4:16 pm | N/A 2033-05-11 | Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks | 0 | $0 | 2,430,400 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:23 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 4:17 pm | N/A 2033-04-25 | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 4:16 pm | N/A 2033-04-25 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 127,500 | $0 | 127,500 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller | 16,100 | $0 | 16,100 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |